
Silencing the DENND1A Gene with Drug Treatment and RNAi to Activate Follicle Rupture in Polycystic Ovarian Syndrome Drosophila melanogaster
This study aims to model the most common female endocrinopathy, Polycystic Ovary
Syndrome (PCOS), in Drosophila melanogaster. If insulin-resistant flies are put on high
glucose diets combined with excessive androgen levels, then Metformin, Clomiphene
Citrate, and RNAi will lessen polycystic symptoms. PCOS symptoms were induced into
insulin-resistant flies by adding 20-hydroxyecdysone to medium to create
hyperandrogenism in the flies, and increasing fructose intake leading to obesity and
hyperglycemia. The effects of Metformin and Clomiphene citrate, common drug
treatments for PCOS, were observed on hemolymph glucose concentration and
fecundity; to test insulin functionality, an insulin sensitivity assay was run. After
induction of PCOS, the DENND1A gene was knocked out using RNAi plasmid
microinjections to observe the function of a human locus in drosophila. To reinforce
successful intake of plasmid dsRNA, a PCR gel was run using primers. Another tested
assay was immunofluorescence microscopy on drosophila ovaries. Drosophila were
embedded, sectioned, and stained with antibodies to observe the anti-EcR receptor
which codes for ecdysone activity, which control ovarian maturation in insects. Overall,
results supported that a polycystic-like disorder can be induced in flies,
hyperandrogenism and hyperglycemia did not significantly increase ovarian ecdysone
activity, and DENND1A function was not significantly reported in fecundity. These
results can be applied to finding novel and cheap methods to research PCOS, as well
as how genetics of the disease function in drosophila. More testing can be done on
environmental factors that may affect genetic factors in certain individuals that make
them prone to certain symptoms.